Cardiac, vascular, and metabolic diseases continue to impose a substantial burden on global healthcare systems. This underscores the pressing need for innovative technologies that enhance patient care and reduce associated costs. In the past decade, advancements in clinical sensing and imaging technologies have shown considerable promise in improving the understanding, diagnosis, and treatment of these diseases. Optoacoustics, also known as photoacoustics, represents a group of cutting-edge sensing and imaging technologies nearing clinical translation.
Particularly in the realms of cardiac, vascular, and metabolic diseases, optoacoustics exhibits exceptional capabilities in characterizing tissue structure, function, and metabolism. This is achieved in a non-invasive manner, without requiring injected contrast agents, and offers high portability and ease of use. By illuminating tissues with laser light, optoacoustics generates ultrasound waves via the optoacoustic effect—producing detailed maps of endogenous light absorbers such as hemoglobin, lipids, and water through the detection of ultrasound in response to light absorption. Recent developments have led to the creation and implementation of several optoacoustic systems in various clinical applications, including cardiovascular monitoring, carotid and peripheral arterial disease assessment, and diabetes mellitus management. The design and introduction of user-friendly clinical optoacoustic systems have significantly enhanced their integration into routine clinical practice, paving the way for widespread point-of-care use.
This research topic aims to explore the latest advancements in translational and clinical optoacoustic sensing and imaging within the context of cardiac, vascular, and metabolic diseases. We welcome submissions that focus on the following areas: development of innovative optoacoustic systems, novel data analytics and processing methods, preliminary and extended clinical studies, and preclinical studies with strong translational potential in the cardio- and vaso-metabolic fields. By compiling state-of-the-art research, we aim to highlight the transformative potential of optoacoustics in improving the diagnosis, treatment, and management of cardiac, vascular, and metabolic diseases.
To gather further insights in the field of cardiovascular and metabolic optoacoustics, we welcome articles addressing, but not limited to, the following themes:
- Development of innovative optoacoustic systems
- Novel data analytics and processing methods
- Preliminary and extended clinical studies
- Preclinical studies with strong translational potential in the cardiovascular and metabolic fields
Keywords:
biomedical imaging, molecular imaging, biomedical sensors, biomedical engineering, medical sensing, photoacoustics, translational imaging
Important Note:
All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.
Cardiac, vascular, and metabolic diseases continue to impose a substantial burden on global healthcare systems. This underscores the pressing need for innovative technologies that enhance patient care and reduce associated costs. In the past decade, advancements in clinical sensing and imaging technologies have shown considerable promise in improving the understanding, diagnosis, and treatment of these diseases. Optoacoustics, also known as photoacoustics, represents a group of cutting-edge sensing and imaging technologies nearing clinical translation.
Particularly in the realms of cardiac, vascular, and metabolic diseases, optoacoustics exhibits exceptional capabilities in characterizing tissue structure, function, and metabolism. This is achieved in a non-invasive manner, without requiring injected contrast agents, and offers high portability and ease of use. By illuminating tissues with laser light, optoacoustics generates ultrasound waves via the optoacoustic effect—producing detailed maps of endogenous light absorbers such as hemoglobin, lipids, and water through the detection of ultrasound in response to light absorption. Recent developments have led to the creation and implementation of several optoacoustic systems in various clinical applications, including cardiovascular monitoring, carotid and peripheral arterial disease assessment, and diabetes mellitus management. The design and introduction of user-friendly clinical optoacoustic systems have significantly enhanced their integration into routine clinical practice, paving the way for widespread point-of-care use.
This research topic aims to explore the latest advancements in translational and clinical optoacoustic sensing and imaging within the context of cardiac, vascular, and metabolic diseases. We welcome submissions that focus on the following areas: development of innovative optoacoustic systems, novel data analytics and processing methods, preliminary and extended clinical studies, and preclinical studies with strong translational potential in the cardio- and vaso-metabolic fields. By compiling state-of-the-art research, we aim to highlight the transformative potential of optoacoustics in improving the diagnosis, treatment, and management of cardiac, vascular, and metabolic diseases.
To gather further insights in the field of cardiovascular and metabolic optoacoustics, we welcome articles addressing, but not limited to, the following themes:
- Development of innovative optoacoustic systems
- Novel data analytics and processing methods
- Preliminary and extended clinical studies
- Preclinical studies with strong translational potential in the cardiovascular and metabolic fields
Keywords:
biomedical imaging, molecular imaging, biomedical sensors, biomedical engineering, medical sensing, photoacoustics, translational imaging
Important Note:
All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.